EAM Investors’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-30,201
| Closed | -$3.24M | – | 404 |
|
|
2023
Q1 | $3.24M | Sell |
30,201
-303
| -1% | -$32.5K | 0.64% | 29 |
|
|
2022
Q4 | $3.36M | Sell |
30,504
-19,550
| -39% | -$2.15M | 0.69% | 24 |
|
|
2022
Q3 | $2.95M | Buy |
+50,054
| New | +$2.95M | 0.64% | 31 |
|
|
2022
Q2 | – | Sell |
-80,587
| Closed | -$3.04M | – | 385 |
|
|
2022
Q1 | $3.04M | Sell |
80,587
-2,177
| -3% | -$82.2K | 0.57% | 46 |
|
|
2021
Q4 | $3.27M | Buy |
+82,764
| New | +$3.27M | 0.54% | 44 |
|